AEON Biopharma Inc - Class A AEON Stock Analysis
- NYSE American
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.16 down $0.05, 24.21% at close Nov 5
Last close · Previous close $0.21
- Market cap
- At the Nov 5 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- NoneLast 12 months
Price chart
$0.16down $0.05, 24.21%Thu, Nov 5 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.21Nov 4
- Volume2.68MNov 5 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.04MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $0.13 to $1.45; now $0.16
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 5 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
AEON trailed the S&P 500 in all 6 periods.
| Period | AEON and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | AEON: down 41.4% S&P 500: down 5.4% | AEON trailed the S&P 500 by 36.0 percentage points Trailed |
| 3M | AEON: down 45.5% S&P 500: down 4.5% | AEON trailed the S&P 500 by 41.0 percentage points Trailed |
| YTD | AEON: down 85.6% S&P 500: up 8.3% | AEON trailed the S&P 500 by 93.9 percentage points Trailed |
| 1Y | AEON: down 84.3% S&P 500: up 9.3% | AEON trailed the S&P 500 by 93.6 percentage points Trailed |
| Long term | ||
| 3Y | AEON: down 100.0% S&P 500: up 74.8% −92.3% vs +20.5% a year | AEON trailed the S&P 500 by 174.8 percentage points Trailed |
| 5Y | AEON: down 100.0% S&P 500: up 67.3% −81.3% vs +10.8% a year | AEON trailed the S&P 500 by 167.3 percentage points Trailed |
$10,000 invested in AEON 5 years ago (Nov 5, 2021) would be worth about $2 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $16,730.
AEON trailed the S&P 500 in all 6 periods.
| Period | AEON and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | AEON: down 41.4% S&P 500: down 5.4% | AEON trailed the S&P 500 by 36.0 percentage points Trailed |
| 3M | AEON: down 45.5% S&P 500: down 4.8% | AEON trailed the S&P 500 by 40.7 percentage points Trailed |
| YTD | AEON: down 85.6% S&P 500: up 7.5% | AEON trailed the S&P 500 by 93.1 percentage points Trailed |
| 1Y | AEON: down 84.3% S&P 500: up 8.2% | AEON trailed the S&P 500 by 92.5 percentage points Trailed |
| Long term | ||
| 3Y | AEON: down 100.0% S&P 500: up 68.6% −92.3% vs +19.0% a year | AEON trailed the S&P 500 by 168.6 percentage points Trailed |
| 5Y | AEON: down 100.0% S&P 500: up 56.4% −81.3% vs +9.4% a year | AEON trailed the S&P 500 by 156.4 percentage points Trailed |
$10,000 invested in AEON 5 years ago (Nov 5, 2021) would be worth about $2 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $15,645.
All-time high
$1,172.88
Closing high on . Now 100.0% below that record.
Split-adjusted daily closes since Apr 12, 2021.
Stock splits
1
1-for-72 on . Share counts adjust after each split.
Valuation
Financials
About AEON Biopharma Inc - Class A
Priveterra Acquisition Corp - Class A
- Sector
- Industry
- Headquarters
- Exchange
- NYSE American
- Asset type
- Common stock
- Price history since
AEON news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
AEON stock FAQ
What is AEON stock’s price today?
AEON Biopharma (AEON) traded at $0.16 at the close on , down $0.05 (24.21%) from the previous close of $0.21. Over the past 52 weeks it has traded between $0.13 and $1.45.
If you invested $1,000 in AEON 5 years ago, how much would you have now?
With dividends reinvested, $1,000 invested in AEON on would be worth about $0 at the close on , a total return of −100.0%. The same $1,000 would be worth $157 if invested one year ago. Past performance doesn’t predict future returns.
Does AEON pay a dividend?
AEON Biopharma hasn’t paid a dividend in the last twelve months.
What is AEON’s 52-week high and low?
Over the past 52 weeks AEON has traded as low as $0.13 and as high as $1.45. At $0.16 at the close on , it is 89.1% below that high and 24.4% above the low.
What is AEON’s all-time high?
AEON’s highest closing price was $1,172.88 on , adjusted for stock splits. At $0.16 at the close on , it is 100.0% below that record.
Has AEON stock ever split?
Yes, once: 1-for-72 on .
How has AEON stock performed?
Including dividends and measured to the close on , AEON has returned −85.6% so far this year and −84.3% over the past year, and −100.0% over five years (−81.3% a year). Over the same periods the S&P 500, measured by SPY, returned +8.3%, +9.3% and +67.3%. Past performance doesn’t predict future returns.
What exchange does AEON trade on?
AEON Biopharma trades on the NYSE American under the ticker symbol AEON. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.